0001609251-24-000004.txt : 20240520 0001609251-24-000004.hdr.sgml : 20240520 20240227131153 ACCESSION NUMBER: 0001609251-24-000004 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240227 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENANTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001177648 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-87373 FILM NUMBER: 24684628 BUSINESS ADDRESS: STREET 1: 500 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617 607 0800 MAIL ADDRESS: STREET 1: 500 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 ORGANIZATION NAME: IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 SCHEDULE 13G 1 primary_doc.xml SCHEDULE 13G 0001609251 XXXXXXXX LIVE COMMON STOCK, Par Value $0.01 Per Share 02/22/2024 0001177648 ENANTA PHARMACEUTICALS INC 29251M106 500 ARSENAL STREET WATERTOWN MA 02472 Rule 13d-1(c) Krensavage Asset Management, LLC a DE 0.00 1086024.00 0.00 1086024.00 1086024.00 5.1 IA KRENSAVAGE PARTNERS LP a DE 0.00 979910.00 0.00 979910.00 979910.00 4.6 PN Krensavage Partners Too, LP a DE 0.00 106114.00 0.00 106114.00 106114.00 0.5 PN ENANTA PHARMACEUTICALS INC 500 ARSENAL STREET , WATERTOWN, MASSACHUSETTS, 02472 (i) Krensavage Partners, LP (KP) with respect to shares of Common Stock directly owned by it. (ii) Krensavage Partners Too, LP (KPT) with respect to shares of Common Stock directly owned by it. (iii) Krensavage Asset Management LLC (KAM) with respect to shares of Common Stock beneficially owned by it. 610 Fifth Avenue, Suite 301 New York, NY 10020 Delaware N IA 1,086,024 5.1% 0 1,086,024 0 1,086,024 Y N N As the discretionary investment manager of the KP and KPT LP's, KAM has the power to direct the voting and disposition of shares held by KP and KPT LP's. Y N See Item(s) 2(a), 2(b), 2(c), 2(d) of Ownership Group - Krensavage Partners, LP (KP) and Krensavage Partners Too, LP (KPT) and Krensavage Asset Management LLC (KAM) Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Krensavage Asset Management, LLC /s/ Paul J. Paolino Chief Financial Officer & Chief Compliance Officer 02/26/2024 KRENSAVAGE PARTNERS LP /s/ Paul J. Paolino Chief Financial Officer & Chief Compliance Officer 02/26/2024 Krensavage Partners Too, LP /s/ Paul J. Paolino Chief Financial Officer & Chief Compliance Officer 02/26/2024